張 又升

研究成果

每年研究成果 2011 2012 2013 2014 2019 2021 2022 2022

• 68 文章
• 3 快報
• 2 評論/辯論
• 1 會議貢獻
• 1 更多
  • 1 回顧型文獻

每年研究成果

每年研究成果

搜尋結果

• 2019

  Corrigendum to “Comparative analysis of novel autoantibody isotypes against citrullinatedinter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis” [J Proteomics 141: (2016) 1–11](S1874391916300860)(10.1016/j.jprot.2016.03.031)

  Liao, C. C., Chou, P. L., Cheng, C. W., Chang, Y. S., Chi, W. M., Tsai, K. L., Chen, W. J., Kung, T. S., Tai, C. C., Lee, K. W., Chen, Y. C. & Lin, C. Y., 3月 1 2019, 於: Journal of Proteomics. 194, p. 227 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  • Trypsin Inhibitors 100%
  • Rheumatology 78%
  • Allergy and Immunology 77%
  • Internal Medicine 74%
  • Taiwan 71%

• Corrigendum to “Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modifiedpeptide adducts in serum of Taiwanese women with rheumatoid arthritis” [J Proteomics 170: (2018) 141–150](S1874391917303020)(10.1016/j.jprot.2017.08.012): (2018) 141–150](S1874391917303020)(10.1016/j.jprot.2017.08.012)

  Liao, C. C., Chang, Y. S., Cheng, C. W., Chi, W. M., Tsai, K. L., Chen, W. J., Kung, T. S., Tai, C. C., Lin, Y. F., Lin, H. T., Lu, Y. Y. & Lin, C. Y., 3月 1 2019, 於: Journal of Proteomics. 194, p. 226 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  • Internal Medicine 100%
  • Taiwan 95%
  • Malondialdehyde 94%
  • Autoantibodies 89%
  • Proteomics 89%
  2 引文 斯高帕斯（Scopus）